Search Results
Results found for "pain modeling"
- Translating computational approaches to GPCR biologists with Dr. Riccardo Capelli | Dr. GPCR Ecosystem
postdoctoral role at the Polytechnic University of Turin (Italy), where he developed coarse-grained models tenure-track position, his research spans the development of computational methods such as structure-based models
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Real-world case studies and data-driven models for pipeline prioritization, resource allocation, and Find the right collaboration model for your program.
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
Why receptor localization and scaffolding dramatically shift functional readouts in disease models. validation under real experimental constraints, Tried to map signaling heterogeneity in disease-relevant models
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
much as a confirmation - if you look in the right system, receptors show you things overexpression models SCIENTIFIC THEMES OF THE CONVERSATION The native cell argument - why overexpression models produce systematically you screen in determines the biology you can find Running a GPCR screen in a HEK cell overexpression model direct product of that discipline - a result that would have been invisible in a standard overexpression model had already won their Nobel Prize 12:39 Co-founding CUE Biotech and Caden Biosciences - allosteric modulator
- Gáspár Pándy-Szekeres | Dr. GPCR Ecosystem
My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since
- Dr. Lukas Grätz | Dr. GPCR Ecosystem
My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models
- Dr. Graham Ladds | Dr. GPCR Ecosystem
His research group uses a combination of pharmacological investigations and mathematical modeling to
- Developing new tools to uncover GPCR signaling patterns with Remi Janicot | Dr. GPCR Ecosystem
Overall, the lab works on diverse models and diseases, and has developed a wide array of tools to dissect
- Dr. Marta Filizola | Dr. GPCR Ecosystem
computational structural biology tools and rational drug design approaches, ranging from molecular modeling
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
the understanding of how an orphan GPCR exerts its effects both in vitro (cell culture and ex vivo models
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fibrosis in acute and chronic mouse models A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
Sam Hoare brings a data analyst's perspective to GPCR pharmacology — one trained in allosteric modulation After a PhD on allosteric modulation of dopamine receptors in Philip Strange's UK lab and a postdoc at biotech and pharmaceutical clients on GPCR data analysis, receptor binding kinetics, and pharmacological modeling The underlying pharmacological theory, from operational models of agonism to allosteric binding equations Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
. 🌟 By teaching with us, you gain: ✔ Premium Membership for you and your team for one year (no credit Course details – title, format (short talk / mini-course / series), audience, main objectives, expected after submission). 🧱 Step 2: Plan Your Course Structure Decide how your course will flow — number of modules
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain (biochemistry, cell biology, genetics) and experimental systems (purified proteins, cultured cells, model Garcia-Marcos's academic journey, which spans training in Spain, Belgium, and a postdoctoral fellowship
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Listeners will gain insight into the scientific reasoning behind GPCR structural studies, the evolving New Tools Enable Re-exploring Old Questions Advances in cryo-EM, computational modeling, and machine That unusual binding mode might explain why it has been so difficult to identify small-molecule ligands Yamina Berchiche: Unless you start thinking about allosteric modulators. Dr. Joseph Kim: Right—and once you start thinking about allosteric modulation, you open an entirely new set
- GPCR Weekly News | Dr. GPCR Ecosystem
Premium members get the complete intelligence. iPSC-Derived GPCR Models — Terry Hébert Live April 16
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
There she focused on the different modes of action of Adhesion GPCRs and found that they do not only different signals on a molecular level and how these are translated into physiological functions in various model
- Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem
By suppressing glutamate release across circuits in the basal ganglia, mGlu2 is positioned to modulate this receptor from the bench to the behaving animal, using optogenetics and circuit-selective mouse models Her lab investigates how GPCRs modulate synaptic transmission in brain circuits involved in reinforcement It is also a complication: a receptor that modulates so many circuits will inevitably produce wanted modulomics - studying circuit-specific GPCR function in the basal ganglia 20:45 Operant behavioral models
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
The result was a structured group management model built around four specialized subgroups, each with 15 - subgroups, leadership training, and delegation 40:41 What excites Gloriam today - open science models
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects
- Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem
His research established the beta-2 adrenergic receptor as the primary model system for understanding Beta-adrenergic receptors as a model system — Why the adrenergic system, with its rich pharmacological
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
validation in GPCR assay design Building reagents that must work in complex tissues, not just simplified models chemistry from the University of Bari in 2018, including research training at the CIQUS Research Center in Spain Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through
- Terms and Conditions | Dr. GPCR Ecosystem
performance of the Services or its components, or (c) modify the Services, or otherwise attempt to gain grant Ecosystem.DrGPCR.com a worldwide, non-exclusive, perpetual, irrevocable, royalty-free, fully paid payment(s) and the terms of Section 4 hereinabove shall survive termination of this ATS, and all fees paid
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
These residues may represent potential targets for allosteric modulators that reshape receptor signaling What were the main questions you were trying to answer? Dr. Nivedha: One of the main topics I worked on was allosteric communication in proteins. And now that I work with peptide drug modalities, I’m interested in peptide-binding GPCRs.
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
Jacobson, Matteo Pavan Structure-Based Design of Modulators of Purinergic GPCRs <p class="font_8">Watch Programs <p class="font_8">Watch Now</p> Terry Hebert GPCR Signaling in iPSC-Derived Cardiac Disease Models Revolution in GPCR Biology <p class="font_8">Watch Now</p> Bryan Roth GPCR Molecular Glues: Biased Modulation Each session begins with a focused presentation from the guest expert, followed by moderated discussion
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind a pre-built mental model for what to freeze, what to protect, and what to let continue.
- Brian Arey - Part 2: GPCR Drug Discovery and the Science Nobody Publishes | Dr. GPCR Ecosystem
and metabolic disease biology, with contributions to multiple clinical programs including preclinical models

























